loader2
NRI

Dec 12, 2024

Category

Equity

AUM (Cr.)

217.92

Exit Load (%)

1.00

Min Inv Lumpsum

5,000

Expense Ratio

2.35

Sharpe Ratio

26.50

Beta Ratio

0.00

Fund Manager

Rohan Korde

Inception Date

Nov 08, 2021

Risk Level

Very High

Investment Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Invest Now
NIFTY Healthcare TRI

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - ITI Pharma and Healthcare Fund (IDCW) 2.7 22.77 45.33 20.05 0 18.9
Benchmark - NIFTY Healthcare TRI 0 0 0 0 0 0
Category Average - BEST EQUITY PERFORMERS 3.96 7.88 30.49 18.84 22.72 18.34
Category Rank 6/5 7/5 6/5 7/5 7/5 5/5
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
SBI Technology Opportunities Fund (IDCW) 139.6400 0.57 39.47 13.90 29.15 4,585.67 1.89 5,000.00 invest
SBI Technology Opportunities Fund (G) 231.8886 0.57 39.47 13.90 29.13 4,585.67 1.89 5,000.00 invest
Franklin Asian Equity Fund (G) 29.1810 0.51 21.94 -1.25 4.30 245.50 0.00 5,000.00 invest
Franklin Asian Equity Fund (IDCW) 13.7740 0.51 21.94 -1.25 4.30 245.50 0.00 5,000.00 invest
Edelweiss Recently Listed IPO Fund (IDCW) 28.4394 -1.38 29.37 10.35 24.35 973.95 2.27 100.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)		 4 Months Trends
Equity-Sun Pharma.Inds. Nov 30, 2024 33.18 15.23 2.12
Equity-Lupin Nov 30, 2024 13.11 6.02 -6.23
Equity-Suven Pharma Nov 30, 2024 12.55 5.76 -0.58
Equity-Aurobindo Pharma Nov 30, 2024 10.57 4.85 29.01
Equity-Divi`s Lab. Nov 30, 2024 10.40 4.77 4.81
Equity-Apollo Hospitals Nov 30, 2024 10.36 4.75 -8.25
Equity-Torrent Pharma. Nov 30, 2024 8.05 3.70 98.39
Equity-Max Healthcare Nov 30, 2024 7.70 3.53 71.85
Equity-Laurus Labs Nov 30, 2024 6.98 3.20 15.45
Equity-Syngene Intl. Nov 30, 2024 5.90 2.71 9.36

latest news

ITI MF announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme

ITI Mutual Fund has announced 12 December 2024 as the record date for decla...

Dec 11, 2024 10:11

ITI Mutual Fund announces change in Key Personnel

ITI Mutual Fund has announced that Mr. Rohan Gandhi has been appointed as a...

Dec 06, 2024 11:21

ITI MF announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme

ITI Mutual Fund has announced 22 November 2024 as the record date for decla...

Nov 19, 2024 09:27

ITI MF announces change in Fund Manager of the following schemes

ITI Mutual Fund has announced change in Fund Managers of the following sche...

Nov 14, 2024 10:21

ITI Mutual Fund Announces Resignation of Key Personnel

ITI Mutual Fund has announced that Mr. Siddhesh Parab, has resigned from th...

Nov 13, 2024 11:05

ITI MF announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme

ITI Mutual Fund has announced 18 October 2024 as the record date for declar...

Oct 16, 2024 09:26

SCHEME DETAILS

AMC Name : ITI Mutual Fund
Fund Name : ITI Pharma and Healthcare Fund (IDCW)
Contact Persone : Rohan Korde
Registered Address : ITI House 36, Dr.R.K.Shirodkar Marg,Parel Mumbai - 400012.
Telephone No : 022-66214999
Fax No. : 022-66214998
Email : mfassist:itiorg.com
Website : www.itiamc.com